RecruitingPhase not listedNCT06433752
A Study Evaluating the Real World Experience of Participants Treated With BRIUMVI® (Ublituximab-xiiy) for Relapsing Multiple Sclerosis (RMS)
Sponsor: TG Therapeutics, Inc.
Billings, MT · +108 more sites
1 recruiting multiple sclerosis studies with a site in Billings, MT.
Sponsor: TG Therapeutics, Inc.
Billings, MT · +108 more sites
Listings come from ClinicalTrials.gov and are provided for information only. Always confirm eligibility with the study team and talk with your doctor before making decisions about your care.